- Published on
41. Ophthalmology – Crouzon Syndrome
Crouzon syndrome is a genetic craniosynostosis disorder characterized by premature fusion of cranial sutures, particularly those of the skull, orbit, and midface. This leads to abnormal development of the cranial vault, orbits, and maxillary complex, producing the classic craniofacial appearance. It occurs in approximately 1 in 60,000 live births and may be inherited in an autosomal dominant pattern or arise from a new (sporadic) mutation. The condition is most commonly associated with mutations in the FGFR2 gene (chromosome 10q25–10q26).
The pathophysiology is based on early suture closure, which restricts skull growth perpendicular to the fused sutures and causes compensatory expansion in other directions. This results in distorted craniofacial anatomy, including shallow orbits and midface hypoplasia. The severity depends on which sutures fuse and how early the fusion occurs.
Ophthalmic manifestations are prominent and often clinically significant. Patients commonly present with proptosis (forward displacement of the eyes) due to shallow orbits, which predisposes to exposure keratopathy, conjunctivitis, and corneal damage. Other ocular findings include hypertelorism (wide-spaced eyes), exotropia (divergent strabismus), refractive errors, and amblyopia. Increased intracranial pressure may lead to papilledema and eventual optic atrophy, resulting in vision loss if untreated. Visual symptoms may include blurred vision, diplopia, irritation, and photophobia.
Systemically, Crouzon syndrome presents with midfacial hypoplasia, a beaked nose, short upper lip, and relative mandibular prognathism. Patients may also develop airway obstruction, obstructive sleep apnea, hearing loss, and dental abnormalities such as a high-arched palate and crowded teeth. A notable associated condition is acanthosis nigricans, presenting as hyperpigmented, velvety skin in flexural areas.
Diagnosis is primarily clinical, supported by genetic testing for FGFR2 mutations. Imaging is essential and includes CT scans with 3D reconstruction to assess cranial suture fusion and orbital anatomy, along with MRI to evaluate intracranial structures and optic nerve status. Additional evaluations often include ophthalmologic exams, audiology testing, and sleep studies.
Management requires a multidisciplinary approach, involving neurosurgery, ophthalmology, craniofacial surgery, and other specialties. Early treatment focuses on cranial decompression (e.g., fronto-orbital advancement) within the first year of life to allow normal brain growth and reduce intracranial pressure. Later procedures, such as midface advancement (e.g., Le Fort III osteotomy), address facial deformities and airway issues. Ophthalmologic care is crucial for preventing amblyopia, managing exposure keratopathy, correcting strabismus, and monitoring optic nerve health.
Long-term follow-up is essential. Patients require ongoing monitoring for vision problems, intracranial pressure changes, and postoperative complications. Prognosis depends on severity, but with timely intervention, most patients can achieve a normal lifespan, although complications such as optic atrophy, airway obstruction, or neurologic impairment may occur if not managed early.
Crouzon syndrome is a genetic craniosynostosis disorder characterized by premature fusion of cranial sutures, particularly those of the skull, orbit, and midface. This leads to abnormal development of the cranial vault, orbits, and maxillary complex, producing the classic craniofacial appearance. It occurs in approximately 1 in 60,000 live births and may be inherited in an autosomal dominant pattern or arise from a new (sporadic) mutation. The condition is most commonly associated with mutations in the FGFR2 gene (chromosome 10q25–10q26).
The pathophysiology is based on early suture closure, which restricts skull growth perpendicular to the fused sutures and causes compensatory expansion in other directions. This results in distorted craniofacial anatomy, including shallow orbits and midface hypoplasia. The severity depends on which sutures fuse and how early the fusion occurs.
Ophthalmic manifestations are prominent and often clinically significant. Patients commonly present with proptosis (forward displacement of the eyes) due to shallow orbits, which predisposes to exposure keratopathy, conjunctivitis, and corneal damage. Other ocular findings include hypertelorism (wide-spaced eyes), exotropia (divergent strabismus), refractive errors, and amblyopia. Increased intracranial pressure may lead to papilledema and eventual optic atrophy, resulting in vision loss if untreated. Visual symptoms may include blurred vision, diplopia, irritation, and photophobia.
Systemically, Crouzon syndrome presents with midfacial hypoplasia, a beaked nose, short upper lip, and relative mandibular prognathism. Patients may also develop airway obstruction, obstructive sleep apnea, hearing loss, and dental abnormalities such as a high-arched palate and crowded teeth. A notable associated condition is acanthosis nigricans, presenting as hyperpigmented, velvety skin in flexural areas.
Diagnosis is primarily clinical, supported by genetic testing for FGFR2 mutations. Imaging is essential and includes CT scans with 3D reconstruction to assess cranial suture fusion and orbital anatomy, along with MRI to evaluate intracranial structures and optic nerve status. Additional evaluations often include ophthalmologic exams, audiology testing, and sleep studies.
Management requires a multidisciplinary approach, involving neurosurgery, ophthalmology, craniofacial surgery, and other specialties. Early treatment focuses on cranial decompression (e.g., fronto-orbital advancement) within the first year of life to allow normal brain growth and reduce intracranial pressure. Later procedures, such as midface advancement (e.g., Le Fort III osteotomy), address facial deformities and airway issues. Ophthalmologic care is crucial for preventing amblyopia, managing exposure keratopathy, correcting strabismus, and monitoring optic nerve health.
Long-term follow-up is essential. Patients require ongoing monitoring for vision problems, intracranial pressure changes, and postoperative complications. Prognosis depends on severity, but with timely intervention, most patients can achieve a normal lifespan, although complications such as optic atrophy, airway obstruction, or neurologic impairment may occur if not managed early.
0 Comments
